Comorbidity profiles among patients with bullous pemphigoid: A nationwide population-based study

British Journal of Dermatology

Volumn 165, Issue 3, 2011, Pages 593-599

  Chen, Y J ^a,d   Wu, C Y ^b,d   Lin, M W ^c   Chen, T J ^e   Liao, K K ^e   Chen, Y C ^f   Hwang, C Y ^a,e   Chu, S Y ^a,e   Chen, C C ^a,e   Lee, D D ^a,e   Chang, Y T ^a,e   Wang, W J ^a,e   Liu, H N ^a,e,g  

^a Departments of Dermatology   (Taiwan)

^b Departments of Internal Medicine   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID; TETRACYCLINE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BULLOUS PEMPHIGOID; COMORBIDITY; DEMENTIA; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; PARKINSON DISEASE; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SEX DIFFERENCE; SKIN DISEASE; SKIN INFLAMMATION; STROKE; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM DISEASES; COMORBIDITY; DERMATITIS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PEMPHIGOID, BULLOUS; PREVALENCE; TAIWAN;

EID: 80052270958     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10386.x     Document Type: Article

References (32)

1. Langan SM, Smeeth L, Hubbard R, et al. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 2008; 337: a180.
2. Chang YT, Liu HN, Yu CW, et al. Cytokine gene polymorphisms in bullous pemphigoid in a Chinese population. Br J Dermatol 2006; 154: 79-84. (Pubitemid 43381324)
3. Risser J, Lewis K, Weinstock MA,. Mortality of bullous skin disorders from 1979 through 2002 in the United States. Arch Dermatol 2009; 145: 1005-8.
4. Groves RW, Liu L, Dopping-Hepenstal PJ, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol 2010; 130: 1551-7.
5. Laffitte E, Burkhard PR, Fontao L, et al. Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis? Br J Dermatol 2005; 152: 537-40. (Pubitemid 40547129)
6. Langan SM, Groves RW, West J,. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. J Invest Dermatol 2011; 131: 631-6.
7. Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 2011; 131: 637-43.
8. Cordel N, Chosidow O, Hellot MF, et al. Neurological disorders in patients with bullous pemphigoid. Dermatology 2007; 215: 187-91. (Pubitemid 47378983)
9. Taghipour K, Chi CC, Vincent A, et al. The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol 2010; 146: 1251-4.
10. Jedlickova H, Hlubinka M, Pavlik T, et al. Bullous pemphigoid and internal diseases-a case-control study. Eur J Dermatol 2010; 20: 96-101.
11. Li L, Chen J, Wang B, et al. Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain. Br J Dermatol 2009; 160: 1343-5.
12. Giannini JM, Callen JP, Gruber GG,. Bullous pemphigoid and rheumatoid arthritis. J Am Acad Dermatol 1981; 4: 695-7. (Pubitemid 11038001)
13. Grattan CE,. Evidence of an association between bullous pemphigoid and psoriasis. Br J Dermatol 1985; 113: 281-3. (Pubitemid 15246602)
14. Davis AL, Bhogal BS, Whitehead P, et al. Lichen planus pemphigoides: its relationship to bullous pemphigoid. Br J Dermatol 1991; 125: 263-71.
15. Wu CY, Wu MS, Kuo KN, et al. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol 2010; 28: 2952-7.
16. Huang YL, Chen YJ, Lin MW, et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol 2009; 161: 854-60.
17. Hwang CY, Chen YJ, Lin MW, et al. Elevated risk of second primary cancer in patients with cutaneous malignant melanoma: a nationwide cohort study in Taiwan. J Dermatol Sci 2010; 60: 167-72.
18. Wu CY, Kuo KN, Wu MS, et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009; 137: 1641-8.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83. (Pubitemid 17055592)
20. Wong SN, Chua SH,. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. Br J Dermatol 2002; 147: 476-80. (Pubitemid 35015280)
21. Yang YW, Chen YH, Xirasagar S, Lin HC,. Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 2011; 42: 319-23.
22. Boussemart L, Jacobelli S, Batteux F, et al. Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reports. Dermatology 2010; 221: 201-5.
23. Bordignon M, Belloni-Fortina A, Pigozzi B, et al. Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology 2009; 219: 357-8.
24. Yamamoti T, Yokoyama A, Mamada A, et al. Familial occurrence of coexistence of bullous pemphigoid and Sjögren's syndrome. Int J Dermatol 1998; 37: 475-6. (Pubitemid 28284884)
25. Taylor G, Venning V, Wojnarowska F, Welch K,. Bullous pemphigoid and autoimmunity. J Am Acad Dermatol 1993; 29: 181-4. (Pubitemid 23221894)
26. Wilczek A, Sticherling M,. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship? Int J Dermatol 2006; 45: 1353-7. (Pubitemid 44688036)
27. StausbÃl-GrÃn B, Deleuran M, Sommer Hansen E, Kragballe K,. Development of bullous pemphigoid during treatment of psoriasis with adalimumab. Clin Exp Dermatol 2009; 34: e285-6.
28. Kirtschig G, Chow ET, Venning VA, Wojnarowska FT,. Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study. Br J Dermatol 1996; 135: 738-45. (Pubitemid 26375891)
29. Kagami S, Kakinuma T, Saeki H, et al. Increased serum CCL28 levels in patients with atopic dermatitis, psoriasis vulgaris and bullous pemphigoid. J Invest Dermatol 2005; 124: 1088-90. (Pubitemid 40629119)
30. Yasukawa S, Dainichi T, Kokuba H, et al. Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2, Treg and Th17 immunological changes. Eur J Dermatol 2009; 19: 69-71.
31. Toosi S, Bystryn JC,. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid. Med Hypotheses 2010; 74: 727-8.
32. Lambiase A, Micera A, Mantelli F, et al. T-helper 17 lymphocytes in ocular cicatricial pemphigoid. Mol Vis 2009; 15: 1449-55.